{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:37:46Z","timestamp":1785523066758,"version":"3.56.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06567-w","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:41:56Z","timestamp":1785170516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpreting the apparent benefit of thoracic radiotherapy in metastatic NSCLC: patient selection and analytical issues remain important\u2014a comment on Xue et al"],"prefix":"10.1007","volume":"152","author":[{"given":"Lili","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"9","key":"6567_CR1","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/cancers16091748","volume":"16","author":"MY Lien","year":"2024","unstructured":"Lien MY, Wang CC, Hwang TZ et al (2024) Programmed death ligand-1 and tumor burden score dictate treatment responses in patients with recurrent or metastatic head and neck squamous cell carcinoma. Cancers (Basel) 16(9):1748. https:\/\/doi.org\/10.3390\/cancers16091748","journal-title":"Cancers (Basel)"},{"key":"6567_CR2","doi-asserted-by":"publisher","first-page":"1572118","DOI":"10.3389\/fonc.2025.1572118","volume":"15","author":"TAD Smith","year":"2025","unstructured":"Smith TAD (2025) An overview of the role of radionuclides in targeted cancer treatment: application of biomarkers for patient selection and developments to improve treatment efficacy. Front Oncol 15:1572118. https:\/\/doi.org\/10.3389\/fonc.2025.1572118","journal-title":"Front Oncol"},{"key":"6567_CR3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/14796694.2026.2652532","volume":"22","author":"F Sun","year":"2026","unstructured":"Sun F, Lu S, Wu M et al (2026) Real-world efficacy of first-line immunochemotherapy combined with thoracic radiotherapy in elderly patients with extensive-stage small cell lung cancer: a single-center retrospective study. Future Oncol 22:1175\u20131188. https:\/\/doi.org\/10.1080\/14796694.2026.2652532","journal-title":"Future Oncol"},{"issue":"11","key":"6567_CR4","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/pharmaceutics16111458","volume":"16","author":"k Tomiyoshi","year":"2024","unstructured":"Tomiyoshi k, Wilson lj, Mourtada f et al (2024) Optimization processes of clinical chelation-based radiopharmaceuticals for pathway-directed targeted radionuclide therapy in oncology. Pharmaceutics 16(11):1458. https:\/\/doi.org\/10.3390\/pharmaceutics16111458","journal-title":"Pharmaceutics"},{"issue":"4","key":"6567_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00432-026-06470-4","volume":"152","author":"L Xue","year":"2026","unstructured":"Xue L, Yao J, Xu Q et al (2026) The efficacy and toxicity of TRT on metastatic NSCLC in patients treated with targeted therapy and chemoimmunotherapy. J Cancer Res Clin Oncol 152(4):86. https:\/\/doi.org\/10.1007\/s00432-026-06470-4","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06567-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06567-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06567-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:22:30Z","timestamp":1785518550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06567-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":5,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["6567"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06567-w","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this article is a commentary on published meta-analysis data and does not involve original research with human participants, patient data, or animal subjects, no ethical approval was required.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"150"}}